Sort
85,873 grants matching “alzheimers”
Presenilin Biology and the Mechanisms of Alzheimer's Disease
$2,096,690Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2016 · AG
Presenilin Biology and the Mechanisms of Alzheimer's Disease
$2,096,690Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2017 · AG
Pre-Clinical Testing Core
$2,096,019Paul Richard Territo · Indiana University Indianapolis · U54 · FY2022 · AG
Genome Engineering an IPSC Model of Alzheimer's Disease
$2,095,914Bruce A Yankner · Harvard Medical School · RF1 · FY2014 · AG
A Phase 2 Trial of AAV-NGF Gene Delivery in Alzheimer's Disease
$2,095,517Paul S. Aisen · University Of California, San Diego · R01 · FY2008 · AG
Presenilin Biology and the Mechanisms of Alzheimer's Disease
$2,095,236Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2018 · AG
Perimenopause in Brain Aging and Alzheimer's Disease
$2,094,712Roberta Diaz Brinton · University Of Arizona · P01 · FY2016 · AG
ALZHEIMER'S DISEASE RESEARCH CENTER
$2,094,552Duke University · P50 · FY2004 · AG
Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regions
$2,094,544Xiangmin Xu · University Of California-Irvine · R01 · FY2023 · AG
Improving the sensitivity and specificity of MRI-based biomarkers in Alzheimer's disease
$2,094,490Paul A. Yushkevich · University Of Pennsylvania · RF1 · FY2021 · AG
Cell Type and Regional Vulnerability in Frontotemporal Dementia
$2,094,351Sally Temple · Regenerative Research Foundation · RF1 · FY2021 · NS
Do Atmospheric Ultrafine Particles Lodge in the Brain and Cause Cognitive Decline Leading to Alzheimer's Disease Related Dementias?
$2,094,256Pamela J Lein · University Of California At Davis · RF1 · FY2022 · NS
Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project
$2,094,019Kristen Jacklin · University Of Minnesota · R01 · FY2024 · AG
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,093,857Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
EXTRAMULAR RESEARCH FACILITIES CONSTRUCTION
$2,093,817J. David Gladstone Institutes · C06 · FY2003 · RR
Introducing Cellular Aging in Human iPS Cells to Investigate Alzheimer Pathogenesis
$2,093,750Hong Zhang · Univ Of Massachusetts Med Sch Worcester · RF1 · FY2017 · AG
Completion of Non-clinical long-term GLP safety and GMP manufacture for first-in-class neuron regenerative therapy, NNI-362 Phase 2 POC AD trial
$2,093,556Judith A Kelleher-Andersson · Neuronascent, Inc. · U01 · FY2024 · AG
Modulation Of Neuronal Channels and Receptors in the Brain
$2,093,404Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Presenilin Biology and the Mechanisms of Alzheimer's Disease
$2,093,246Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2014 · AG
Neuroimaging Predictors of Cognitive Decline and Impairment
$2,092,921Susan Resnick · National Institute On Aging · ZIA · FY2016 · AG
Selective neuronal silencing to study cognitive decline in Alzheimer's disease
$2,092,130Joanna L Jankowsky · Baylor College Of Medicine · DP2 · FY2007 · OD
National Social Life and Aging Project: Wave 4
$2,091,713Linda J Waite · National Opinion Research Center · R01 · FY2022 · AG
Dementia with Lewy Bodies Consortium
$2,091,032James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · U01 · FY2022 · NS
Investigating Pathways from Adverse Pregnancy Outcomes to Alzheimer's Disease and Related Dementias: the nuMoM2b-Brain Study
$2,090,311Eliza C Miller · Columbia University Health Sciences · R01 · FY2024 · AG
Characterizing and Targeting Pyk2 Kinase in Alzheimerâs Disease
$2,090,105Stephen M Strittmatter · Yale University · RF1 · FY2016 · AG